F.D.A. Panel Backs Limits on Testosterone Drugs

New York Times: HYATTSVILLE, Md. —  An expert panel voted overwhelmingly on Wednesday for the Food and Drug Administration to impose strict new limitations on the multibillion-dollar testosterone drug industry, which would tighten labels for the medicines so they are not prescribed to men who only have problems related to aging, such as low energy and libido. The F.D.A. often takes the advice of such panels.

Read article